Research of the Correlation Between Metabolic Syndrome, Retinal Thickness and Visual Acuity
This study has been completed.
Sponsor:
Taipei Medical University WanFang Hospital
Information provided by:
Taipei Medical University WanFang Hospital
ClinicalTrials.gov Identifier:
NCT01219478
First received: October 10, 2010
Last updated: December 19, 2010
Last verified: December 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Purpose: To investigate the relationship between retinal thickness (RT) and metabolic risks (MRs) in patients without retinal lesion.
Methods: Fifty-two patients over 60 y/o were divided into four groups according to their MRs of hypertension, hyperlipidemia or hyperglyceremia. After complete ophthalmic examination, optical coherence tomography was performed to measure RT.
| Condition |
|---|
|
Visual Acuity |
| Study Type: | Observational |
| Study Design: | Time Perspective: Retrospective |
| Official Title: | Research of the Correlation Between Metabolic Syndrome, Retinal Thickness and Visual Acuity |
Resource links provided by NLM:
Further study details as provided by Taipei Medical University WanFang Hospital:
| Enrollment: | 100 |
| Study Start Date: | January 2009 |
| Study Completion Date: | December 2009 |
| Groups/Cohorts |
|---|
|
control
0 metabloil risk
|
|
1
1 metabloil risk
|
|
2
2 metabloil risk
|
|
3
3 metabloil risk
|
Eligibility| Ages Eligible for Study: | 65 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
Patients who were over 60 y/o were divided into four groups according to their MRs of hypertension, hyperlipidemia or hyperglyceremia.
Criteria
Inclusion Criteria:
- We enrolled the patients included age more than 60 years old, no positive finding during dilated fundus examination.
Exclusion Criteria:
The exclusion criteria were as followed:
- systemic disease that will affect visual acuity evaluation (for example: CVA), *opaque cornea and vitreous
- glaucoma
- uvietis and other clinically established ocular disease.
- According to the LOCS III11, those who had nuclear opalescence, nuclear color more than grade 3 or any grade of cortical cataract and posterior subcapsular cataract were also eliminated.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01219478
Locations
| Taiwan | |
| Taipei Medical University - WanFang Hospital | |
| Taipei, Taiwan | |
Sponsors and Collaborators
Taipei Medical University WanFang Hospital
Investigators
| Principal Investigator: | Hui-Chun Ho | Taipei Medical University WanFang Hospital |
More Information
No publications provided
| Responsible Party: | Hui-Chun Ho, Department of Ophthalmology, Wanfang Hospital |
| ClinicalTrials.gov Identifier: | NCT01219478 History of Changes |
| Other Study ID Numbers: | 99028 |
| Study First Received: | October 10, 2010 |
| Last Updated: | December 19, 2010 |
| Health Authority: | Taiwan: Department of Health |
Keywords provided by Taipei Medical University WanFang Hospital:
|
To investigate the relationship between retinal thickness (RT) and metabolic risks (MRs) in patients without retinal lesion |
Additional relevant MeSH terms:
|
Metabolic Syndrome X Insulin Resistance Hyperinsulinism Glucose Metabolism Disorders Metabolic Diseases |
ClinicalTrials.gov processed this record on May 16, 2013